NPR News

CNN. ABC News. The New York Times. Fox News.

Those are the publishers of four of the five most popular Facebook posts of articles about the Johnson & Johnson Covid-19 vaccine this week. They're ranked 2-5 in total interactions, according to data from the tracking tool Crowdtangle.

Number one however, isn't from a news organization. Or a government official. Or a public health expert.

Members of Congress on Thursday will hear for the first time public testimony from the U.S. Capitol Police inspector general that will detail the most extensive findings yet in the wake of the Jan. 6 insurrection.

For months, stories swirled around a prominent Muslim civil rights leader, alleging secret marriages, bullying, sexual harassment.

Then, late last year, some of the allegations against 34-year-old Hassan Shibly burst into public view. In a video posted on GoFundMe, Shibly's estranged wife, mother of their three children, looked directly into the camera and begged for help. She said her abusive husband had cut her off financially.

One recent tweet from New York Sen. Kirsten Gillibrand — along with its reams of snarky responses — sums up a key divide over infrastructure in Washington right now.

"Paid leave is infrastructure. Child care is infrastructure. Caregiving is infrastructure," she wrote.

President Biden is selling the climate friendly aspects of his $2 trillion infrastructure plan as a chance to create good-paying union jobs. But at a local branch of one of the country's oldest unions, there are doubts that dealing with climate change will be good for workers here, in the oil-and-gas state of Pennsylvania.

Coinbase, a San Francisco startup that allows people to buy and sell digital currency, became the first major cryptocurrency company to go public when it made its stock market debut on Wednesday.

Trading began around $381 a share, pushing the company's valuation close to $100 billion. That's about what Facebook was worth when it had its initial public offering in 2012.

The Department of Justice announced Wednesday it will not pursue charges against the U.S. Capitol Police officer who fatally shot a rioter inside the Capitol building on Jan. 6. Officials determined there wasn't enough evidence to support a criminal prosecution.

An expert advisory committee to the Centers for Disease Control and Prevention decided Wednesday it needed more time to consider whether to recommend to resume administering the COVID-19 vaccine made by Johnson & Johnson.

One in 4 Americans would refuse a coronavirus vaccine if offered, a recent NPR/Marist poll found. Another 5% are "undecided" about whether they would get the shot. And some researchers are growing worried that this reluctance will be enough to prevent the nation from reaching what's known as herd immunity.